List of WILEX patents

Patents where

Current Assignee

Name

‌

WILEX

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7342018 Urokinase inhibitors and uses thereof	Patent 7342018 was granted and assigned to WILEX on March, 2008 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7342018	March 11, 2008
‌ US Patent 7807681 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors	Patent 7807681 was granted and assigned to WILEX on October, 2010 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7807681	October 5, 2010
‌ US Patent 8461321 Nucleic acids encoding a deletion variant of uPAR	Patent 8461321 was granted and assigned to WILEX on June, 2013 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8461321	June 11, 2013
‌ US Patent RE46424 Method for producing 3-amidinophenylalanine derivatives	Patent RE46424 was granted and assigned to WILEX on June, 2017 by the United States Patent and Trademark Office.	‌ WILEX	‌ WILEX	United States Patent and Trademark Office	RE46424	June 6, 2017
‌ US Patent 7745441 Urokinase inhibitors	Patent 7745441 was granted and assigned to WILEX on June, 2010 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7745441	June 29, 2010
‌ US Patent 7659396 Method for the production of phenylalanine derivatives	Patent 7659396 was granted and assigned to WILEX on February, 2010 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7659396	February 9, 2010
‌ US Patent 7691375 Adjuvant theraphy of G250-expressing tumors	Patent 7691375 was granted and assigned to WILEX on April, 2010 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7691375	April 6, 2010
‌ US Patent 8642761 Method for producing 3-amidinophenylalanine derivatives	Patent 8642761 was granted and assigned to WILEX on February, 2014 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8642761	February 4, 2014
‌ US Patent 8492385 Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof	Patent 8492385 was granted and assigned to WILEX on July, 2013 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8492385	July 23, 2013
‌ US Patent 8492520 Binding epitopes for G250 antibody	Patent 8492520 was granted and assigned to WILEX on July, 2013 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8492520	July 23, 2013
‌ US Patent 8093258 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases	Patent 8093258 was granted and assigned to WILEX on January, 2012 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8093258	January 10, 2012
‌ US Patent 8088921 Method for producing 3-amidinophenylalanine derivatives	Patent 8088921 was granted and assigned to WILEX on January, 2012 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	8088921	January 3, 2012
‌ US Patent 7211670 Method for producing 3-amidinophenylalanine derivatives	Patent 7211670 was granted and assigned to WILEX on May, 2007 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7211670	May 1, 2007
‌ US Patent 10620208 Classifying a cancer disease using CAIX expression		‌ WILEX	‌ WILEX	United States Patent and Trademark Office	10620208	April 14, 2020
‌ US Patent 7314863 Cyclic peptidomimetic urokinase receptor antagonists	Patent 7314863 was granted and assigned to WILEX on January, 2008 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7314863	January 1, 2008
‌ US Patent 9605075 Hybridoma cell line G250 and its use for producing monoclonal antibodies	Patent 9605075 was granted and assigned to WILEX on March, 2017 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	9605075	March 28, 2017
‌ US Patent 7884206 Method for producing 3-amidinophenylalanine derivatives	Patent 7884206 was granted and assigned to WILEX on February, 2011 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7884206	February 8, 2011
‌ US Patent 7208521 Selective inhibitors of the urokinase plasminogen activator	Patent 7208521 was granted and assigned to WILEX on April, 2007 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7208521	April 24, 2007
‌ US Patent 7407751 Methods for the detection and prognosis of breast tumors	Patent 7407751 was granted and assigned to WILEX on August, 2008 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7407751	August 5, 2008
‌ US Patent 7951943 Method for preparing and purifying 3-hydroxyamidinophenylalanine compounds	Patent 7951943 was granted and assigned to WILEX on May, 2011 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7951943	May 31, 2011
‌ US Patent 7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor	Patent 7399468 was granted and assigned to WILEX on July, 2008 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7399468	July 15, 2008
‌ US Patent 7247724 Method for the production of phenylalanine derivatives	Patent 7247724 was granted and assigned to WILEX on July, 2007 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7247724	July 24, 2007
‌ US Patent 7632496 Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas	Patent 7632496 was granted and assigned to WILEX on December, 2009 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7632496	December 15, 2009
‌ US Patent 7538216 Guanidino phenylalanin compounds used as urokinase inhibitors	Patent 7538216 was granted and assigned to WILEX on May, 2009 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7538216	May 26, 2009
‌ US Patent 7608623 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors	Patent 7608623 was granted and assigned to WILEX on October, 2009 by the United States Patent and Trademark Office.		‌ WILEX	United States Patent and Trademark Office	7608623	October 27, 2009

Results per page:

35 results

0 selected

35 results

0 selected